Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_assertion type Assertion NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_head.
- NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_assertion description "[For colorectal carcinoma, IL-1B-511 heterozygotes (OR, 0.34; 95% CI, 0.2-0.7; p=0.0028) and T carriers (OR, 0.43; 95% CI, 0.2-0.9; p=0.0015) had a significantly low risk of carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_provenance.
- NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_assertion evidence source_evidence_literature NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_provenance.
- NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_assertion SIO_000772 17611673 NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_provenance.
- NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_assertion wasDerivedFrom befree-20140225 NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_provenance.
- NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_assertion wasGeneratedBy ECO_0000203 NP619295.RAR2hrUSbavL8FFVeFGR7fmLrKXwU7GDapdqduxr8ri04130_provenance.